Amgen names new Director.

M2 EQUITYBITES-August 4, 2022-Amgen names new Director

(C)2022 M2 COMMUNICATIONS http://www.m2.com

United States-based pharmaceutical company Amgen (NASDAQ: AMGN) announced on Wednesday that it has named Michael V Drake, MD, as its new director, effective immediately.

In addition to the newly appointed role, Dr Drake will also serve as a member of the board's Corporate Responsibility and Compliance Committee and its Governance and Nominating Committee.

Dr Drake currently serves as the president of the University of California. He has...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT